Skip to content

The Effect of Periodontal Treatment on Psoriasis

Effects of Non-surgical Periodontal Therapy on Inflammatory Markers of Psoriasis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03939936
Enrollment
92
Registered
2019-05-07
Start date
2017-05-01
Completion date
2018-02-15
Last updated
2019-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases

Keywords

Psoriasis

Brief summary

There is a relationship between psoriasis and periodontal disease. This relationship may be double-sided.

Detailed description

The aim of this randomized controlled clinical study was to determine the effect of non-surgical mechanical periodontal treatment on psoriasis. The study population consisted of 92 periodontitis patients with psoriasis who had untreated periodontal disease. Two randomized groups were formed from these patients. Immediate periodontal treatment (test group, n = 46) and delayed periodontal treatment (control group, n = 46). Clinical periodontal measures, saliva interleukin 2, interleukin 6 and secretory immunoglobulin A levels and PASI scores were performed at baseline and 8th week in control and test group.

Interventions

OTHERPsoriatic measurements

Psoriasis Area and Severity Index (PASI) was performed baseline and after 8 weeks. Saliva samples were taken from patients for the evaluation of proinflammatory cytokine baseline and after 8 weeks.

OTHERNon-surgical periodontal treatment

Non-surgical periodontal treatment was performed baseline and after 8 weeks. Saliva samples were taken from patients for the evaluation of proinflammatory cytokine baseline and after 8 weeks.

Saliva samples were taken from patients for the evaluation of proinflammatory cytokine baseline and after 8 weeks.

Sponsors

Ozge Gokturk
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* the presence at least 20 remaining teeth, * the presence of Stage I or Stage II Periodontitis, * the presence of diagnosed psoriasis.

Exclusion criteria

* patients who had the immune-inflammatory disease and require antibiotic prophylaxis, * patients who received periodontal treatment prior to 6 months, * women who were breastfeeding or pregnant, * patients using medicines such as antibiotics, anti-inflammatory drugs, immune-suppressants.

Design outcomes

Primary

MeasureTime frameDescription
Proinflammatory cytokinesBaseline and after 8 weeksThe changes in proinflammatory cytokines levels within 8 weeks. Higher values represent a worse outcome. The decrease in proinflammatory cytokines levels is expected after periodontal treatment.

Secondary

MeasureTime frameDescription
Gingival indexBaseline and after 8 weeksThe changes in gingival index level after periodontal treatment. Gingival index was measured for determining the severity of disease and clinical outcome. Higher values represent a worse outcome. After periodontal treatment, a reduction in gingival index value is expected.
PASI indexBaseline and after 8 weeksThe changes in PASI index level after periodontal treatment. PASI index was measured for determining the severity of psoriasis disease. Higher values represent a worse outcome. After periodontal treatment, a reduction in PASI index value is expected.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026